Frequency Therapeutics, Inc is a biotechnology business based in the US. Frequency Therapeutics shares (FREQ) are listed on the NASDAQ and all prices are listed in US Dollars. Frequency Therapeutics employs 83 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Frequency Therapeutics
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – FREQ – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Frequency Therapeutics stock price (NASDAQ: FREQ)Use our graph to track the performance of FREQ stocks over time.
Frequency Therapeutics shares at a glance
|Latest market close||$8.85|
|52-week range||$7.34 - $58.37|
|50-day moving average||$9.33|
|200-day moving average||$22.51|
|Wall St. target price||$16.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.64|
Buy Frequency Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Frequency Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Frequency Therapeutics price performance over time
|1 week (2021-07-18)||N/A|
|1 month (2021-06-29)||-11.23%|
|3 months (2021-04-29)||-20.77%|
|6 months (2021-01-25)||N/A|
|1 year (2020-07-25)||N/A|
|2 years (2019-07-25)||N/A|
|3 years (2018-07-25)||N/A|
|5 years (2016-07-25)||N/A|
Frequency Therapeutics financials
|Revenue TTM||$34.4 million|
|Gross profit TTM||$5 million|
|Return on assets TTM||-11.51%|
|Return on equity TTM||-24.53%|
|Market capitalisation||$269.6 million|
TTM: trailing 12 months
Shorting Frequency Therapeutics shares
There are currently 5.5 million Frequency Therapeutics shares held short by investors – that's known as Frequency Therapeutics's "short interest". This figure is 8.6% down from 6.0 million last month.
There are a few different ways that this level of interest in shorting Frequency Therapeutics shares can be evaluated.
Frequency Therapeutics's "short interest ratio" (SIR)
Frequency Therapeutics's "short interest ratio" (SIR) is the quantity of Frequency Therapeutics shares currently shorted divided by the average quantity of Frequency Therapeutics shares traded daily (recently around 537557.22713864). Frequency Therapeutics's SIR currently stands at 10.17. In other words for every 100,000 Frequency Therapeutics shares traded daily on the market, roughly 10170 shares are currently held short.
However Frequency Therapeutics's short interest can also be evaluated against the total number of Frequency Therapeutics shares, or, against the total number of tradable Frequency Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Frequency Therapeutics's short interest could be expressed as 0.16% of the outstanding shares (for every 100,000 Frequency Therapeutics shares in existence, roughly 160 shares are currently held short) or 0.18% of the tradable shares (for every 100,000 tradable Frequency Therapeutics shares, roughly 180 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Frequency Therapeutics.
Find out more about how you can short Frequency Therapeutics stock.
Frequency Therapeutics share dividends
We're not expecting Frequency Therapeutics to pay a dividend over the next 12 months.
Frequency Therapeutics overview
Frequency Therapeutics, Inc. , a clinical-stage biotechnology company, focuses on harnessing the body's innate biology to repair or reverse damage caused by a range of degenerative diseases. Its Progenitor Cell Activation approach, uses combinations of small molecules to activate progenitor cells within the body to create functional tissue. The company's lead product candidate is FX-322, which is in Phase IIa clinical trial to treat the underlying cause of sensorineural hearing loss. It is also developing medicines for patients across a range of degenerative conditions, including multiple sclerosis, and diseases of the muscle, gastrointestinal tract, skin, and bone. Frequency Therapeutics, Inc. has a licencse and collaboration agreement with Astellas Pharma Inc.
Stocks similar to Frequency Therapeutics
Frequency Therapeutics in the news
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Frequency, Athira, Full Truck, and Coinbase and Encourages Investors to Contact the Firm
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Frequency Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - FREQ
FREQ LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Frequency Therapeutics, Inc.
Frequently asked questionsWhat percentage of Frequency Therapeutics is owned by insiders or institutions?
Currently 12.329% of Frequency Therapeutics shares are held by insiders and 60.161% by institutions. How many people work for Frequency Therapeutics?
Latest data suggests 83 work at Frequency Therapeutics. When does the fiscal year end for Frequency Therapeutics?
Frequency Therapeutics's fiscal year ends in December. Where is Frequency Therapeutics based?
Frequency Therapeutics's address is: 75 Hayden Avenue, Lexington, MA, United States, 02421 What is Frequency Therapeutics's ISIN number?
Frequency Therapeutics's international securities identification number is: US35803L1089 What is Frequency Therapeutics's CUSIP number?
Frequency Therapeutics's Committee on Uniform Securities Identification Procedures number is: 35803L108
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert